CHRS - Coherus BioSciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CHRS is currently covered by 8 analysts with an average price target of $9.69. This is a potential upside of $8.38 (639.69%) from yesterday's end of day stock price of $1.31.

Coherus BioSciences's activity chart (see below) currently has 105 price targets and 92 ratings on display. The stock rating distribution of CHRS is 84% BUY and 16% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10.26% with an average time for these price targets to be met of 79.69 days.

Highest price target for CHRS is $7, Lowest price target is $1.05, average price target is $7.29.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 04-Sep-2025. First documented stock forecast 27-Jul-2016.

Currently out of the existing stock ratings of CHRS, 21 are a BUY (84%), 4 are a HOLD (16%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$4

$2.71 (210.08%)

6 days ago
(04-Sep-2025)

3/9 (33.33%)

$2.69 (205.34%)

181

Buy

$7

$5.71 (442.64%)

$7

4 months 12 days ago
(29-Apr-2025)

0/16 (0%)

$6 (600.00%)

Hold

$1.05

$-0.24 (-18.60%)

$1.5

4 months 17 days ago
(24-Apr-2025)

2/4 (50%)

$0.04 (3.96%)

58

Buy

$7

$5.71 (442.64%)

$7

1 years 3 months 28 days ago
(13-May-2024)

0/5 (0%)

$4.91 (234.93%)

Buy

$11

$9.71 (752.71%)

1 years 5 months 21 days ago
(20-Mar-2024)

0/4 (0%)

$8.52 (343.55%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CHRS (Coherus BioSciences) average time for price targets to be met?

On average it took 79.69 days on average for the stock forecasts to be realized with a an average price target met ratio 10.26

Which analyst has the current highest performing score on CHRS (Coherus BioSciences) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on CHRS (Coherus BioSciences)?

Jason Mccarthy works at MAXIM GROUP and has 2 price targets and 2 ratings on CHRS

Which analyst is the currently most bullish on CHRS (Coherus BioSciences)?

Michael Ulz with highest potential upside - $28.71

Which analyst is the currently most reserved on CHRS (Coherus BioSciences)?

Ashwani Verma with lowest potential downside - -$0.24

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?